These results, along with recent evidence that eIF4E contributes to CLL cell survival [37], also suggest that eIF4E activity is another target of the anti-apoptotic Notch signaling in CLL, in addition to Mcl-1. The gene discussed is EIF4E; the disease is B-cell chronic lymphocytic leukemia.